B Merle1,2, R Chapurlat3, E Vignot3, T Thomas4, J Haesebaert5, A-M Schott5. 1. INSERM Unit 1033, Université de Lyon, Service de Rhumatologie, Hospices Civils de Lyon, Lyon, France. blandine.merle@inserm.fr. 2. INSERM Unit 1033, Department of Rheumatology, Hôpital Edouard Herriot, Pavillon F, Place d'Arsonval, 69437, Lyon, France. blandine.merle@inserm.fr. 3. INSERM Unit 1033, Université de Lyon, Service de Rhumatologie, Hospices Civils de Lyon, Lyon, France. 4. Service de Rhumatologie, INSERM Unit 1059, Hôpital Bellevue, Saint-Etienne, France. 5. Hospices Civils de Lyon, EA 7425 HeSPeR Unit, Université de Lyon, Lyon, France.
Abstract
We conducted a multicenter, randomized controlled trial to evaluate the impact of a population-based patient-centered post-fracture care program with a dedicated case manager, PREVention of OSTeoporosis (PREVOST), on appropriate post-fracture osteoporosis management. We showed that, compared to usual care, BMD investigation post-fracture was significantly improved (+20%) by our intervention program. INTRODUCTION: Our study aims to evaluate the impact of a population-based patient-centered post-fracture care program, PREVOST, on appropriate post-fracture care. METHODS: Multicenter, randomized controlled trial enrolling 436 women aged 50 to 85 years and attending a French hospital, for a low-energy fracture of the wrist or humerus. Randomization was stratified by age, hospital department, and site of fracture. The intervention was performed by a trained case manager who interacted only with the patients, with repeated oral and written information about fragility fractures and osteoporosis management, and prompting them to visit their primary care physicians. Control group received usual care. The primary outcome was the initiation of an appropriate post-fracture care defined by Bone Mineral Density (BMD) and/or anti-osteoporotic treatment prescription at 6 months. RESULTS: At 6 months, 53% of women in intervention group initiated a post-fracture care versus 33% for usual care (adjOR 2.35, 95%CI [1.58-3.50], p < 0.001). Post-fracture care was more frequent after wrist than humerus fracture (adjOR 1.93, 95%CI [1.14-3.30], p = 0.015) and decreased with age (adjOR for 10 years increase 0.76, 95%CI [0.61-0.96], p = 0.02). The intervention resulted in BMD prescription in 50% of patients (adjOR 2.10, 95%CI [1.41-3.11], p < 0.001) and in BMD performance in 41% of patients (adjOR 2.12, 95%CI [1.40-3.20], p < 0.001) versus 33 and 25% for usual care, respectively. Having performed a BMD increased treatment prescription; however, only 46% of women with a low BMD requiring a treatment according to the French guidelines received a prescription. CONCLUSION: A patient-centered care program with a dedicated case manager can significantly improve post-fracture BMD investigation.
RCT Entities:
We conducted a multicenter, randomized controlled trial to evaluate the impact of a population-based patient-centered post-fracture care program with a dedicated case manager, PREVention of OSTeoporosis (PREVOST), on appropriate post-fracture osteoporosis management. We showed that, compared to usual care, BMD investigation post-fracture was significantly improved (+20%) by our intervention program. INTRODUCTION: Our study aims to evaluate the impact of a population-based patient-centered post-fracture care program, PREVOST, on appropriate post-fracture care. METHODS: Multicenter, randomized controlled trial enrolling 436 women aged 50 to 85 years and attending a French hospital, for a low-energy fracture of the wrist or humerus. Randomization was stratified by age, hospital department, and site of fracture. The intervention was performed by a trained case manager who interacted only with the patients, with repeated oral and written information about fragility fractures and osteoporosis management, and prompting them to visit their primary care physicians. Control group received usual care. The primary outcome was the initiation of an appropriate post-fracture care defined by Bone Mineral Density (BMD) and/or anti-osteoporotic treatment prescription at 6 months. RESULTS: At 6 months, 53% of women in intervention group initiated a post-fracture care versus 33% for usual care (adjOR 2.35, 95%CI [1.58-3.50], p < 0.001). Post-fracture care was more frequent after wrist than humerus fracture (adjOR 1.93, 95%CI [1.14-3.30], p = 0.015) and decreased with age (adjOR for 10 years increase 0.76, 95%CI [0.61-0.96], p = 0.02). The intervention resulted in BMD prescription in 50% of patients (adjOR 2.10, 95%CI [1.41-3.11], p < 0.001) and in BMD performance in 41% of patients (adjOR 2.12, 95%CI [1.40-3.20], p < 0.001) versus 33 and 25% for usual care, respectively. Having performed a BMD increased treatment prescription; however, only 46% of women with a low BMD requiring a treatment according to the French guidelines received a prescription. CONCLUSION: A patient-centered care program with a dedicated case manager can significantly improve post-fracture BMD investigation.
Authors: D Marsh; K Akesson; D E Beaton; E R Bogoch; S Boonen; M-L Brandi; A R McLellan; P J Mitchell; J E M Sale; D A Wahl Journal: Osteoporos Int Date: 2011-05-24 Impact factor: 4.507
Authors: W D Leslie; L M Giangregorio; M Yogendran; M Azimaee; S Morin; C Metge; P Caetano; L M Lix Journal: Osteoporos Int Date: 2011-04-08 Impact factor: 4.507
Authors: Sumit R Majumdar; Jeffrey A Johnson; Finlay A McAlister; Debbie Bellerose; Anthony S Russell; David A Hanley; Don W Morrish; Walter P Maksymowych; Brian H Rowe Journal: CMAJ Date: 2008-02-26 Impact factor: 8.262
Authors: H Spechbach; I Fabreguet; E Saule; M Hars; J Stirnemann; S Ferrari; R Rizzoli; T Chevalley Journal: Osteoporos Int Date: 2019-02-28 Impact factor: 4.507
Authors: B Merle; C Dupraz; J Haesebaert; L Barraud; M Aussedat; C Motteau; V Simon; A M Schott; M Flori Journal: Osteoporos Int Date: 2018-10-10 Impact factor: 4.507
Authors: D Pinto; M Alshahrani; R Chapurlat; T Chevalley; E Dennison; B M Camargos; A Papaioannou; S Silverman; J-F Kaux; N E Lane; J Morales Torres; J Paccou; R Rizzoli; O Bruyere Journal: Osteoporos Int Date: 2022-01-20 Impact factor: 4.507